ClinicalTrials.govpublic full text
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
recurrent nasopharyngeal carcinoma, nimotuzumab, imrt, radiation, recurrent, nasopharyngeal carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892156
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.